Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-31 @ 8:06 PM
Study NCT ID:
NCT01689558
Status:
UNKNOWN
Last Update Posted:
2013-03-12
First Post:
2012-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer
Sponsor:
Jin Feng
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-08-12
First Submit QC Date:
None
Study First Post Date:
2012-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-11
Last Update Post Date:
2013-03-12
Last Update Post Date Type:
ESTIMATED